Clinical Trial

A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPD

Name: A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPD — clinical trial record (NCT07658339)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the efficacy and safety of HSK39004 Inhalation Suspension in patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).

Trial Details

NCT Number	NCT07658339
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd.
Conditions	COPD (Chronic Obstructive Pulmonary Disease)
Enrollment	387 participants
Start Date	2026-07-11
Primary Completion	2027-06-11 (estimated)
Study Completion	2027-06-11 (estimated)
Updated on ClinicalTrials.gov	2026-06-22